MENU
+Compare
FSNUF
Stock ticker: OTC
AS OF
Jul 16 closing price
Price
$46.21
Change
-$1.36 (-2.86%)
Capitalization
17.71B

FSNUF stock forecast, quote, news & analysis

Fresenius SE is a healthcare holding company based in Germany... Show more

FSNUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for FSNUF with price predictions
Aug 05, 2025

FSNUF's RSI Oscillator is remaining in oversold zone for 14 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Momentum Indicator moved above the 0 level on July 30, 2025. You may want to consider a long position or call options on FSNUF as a result. In of 45 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

FSNUF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 182 cases where FSNUF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

FSNUF moved below its 50-day moving average on August 01, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for FSNUF crossed bearishly below the 50-day moving average on August 01, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FSNUF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.796) is normal, around the industry mean (4.275). P/E Ratio (12.563) is within average values for comparable stocks, (74.174). Projected Growth (PEG Ratio) (1.379) is also within normal values, averaging (1.595). Dividend Yield (0.031) settles around the average of (0.025) among similar stocks. P/S Ratio (0.395) is also within normal values, averaging (9.167).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FSNUF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FSNUF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
published Dividends

FSNUF paid dividends on May 27, 2021

Fresenius SE & Co. KGaA FSNUF Stock Dividends
А dividend of $0.88 per share was paid with a record date of May 27, 2021, and an ex-dividend date of May 24, 2021. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 4.39B. The market cap for tickers in the group ranges from 1.86K to 88.21B. HCA holds the highest valuation in this group at 88.21B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was -1%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -0%. KJFI experienced the highest price growth at 70%, while AGL experienced the biggest fall at -54%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was 473%. For the same stocks of the Industry, the average monthly volume growth was 883% and the average quarterly volume growth was 660%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 67
Price Growth Rating: 63
SMR Rating: 79
Profit Risk Rating: 82
Seasonality Score: -16 (-100 ... +100)
View a ticker or compare two or three
FSNUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
Else-Kroener-Strasse 1
Phone
+49 61726080
Employees
316920
Web
https://www.fresenius.com